GOVX · GeoVax Labs, Inc.

Geovax Labs Inc Is A Clinical-Stage Biotechnology Company Developing Human Vaccines And Immunotherapies Against Infectious Diseases And Solid Tumor Cancers Using Novel Proprietary Platforms. The Company Is Focused On The Advancement Of Geo-Mva, A Modified Vaccinia Ankara (Mva) Vaccine Candidate For Mpox, Smallpox, And Other Poxviruses. Its Flagship Clinical Program In Oncology Is Gedeptin, A Novel Oncolytic Solid Tumor Gene-Directed Therapy, Which Recently Completed A Multicenter Phase 1/2 Clinical Trial For Head And Neck Cancers. The Company Is Also Developing Geo-Cm04s1, A Next-Generation Multi-Antigen Covid-19 Vaccine, Which Is Currently Being Evaluated In Two Phase 2 Clinical Trials.